Suppression of fibroblast growth factor-2 expression: Possible mechanism underlying methylmercury-induced inhibition of the repair of wounded monolayers of cultured human brain microvascular endothelial cells

Journal of Toxicological Sciences

Volumn 34, Issue 4, 2009, Pages 433-439

  Hirooka, Takashi ^a   Fujiwara, Yasuyuki ^b   Inoue, Shoko ^a   Shinkai, Yasuhiro ^a   Yamamoto, Chika ^a   Satoh, Masahiko ^b   Yasutake, Akira ^c   Eto, Komyo ^d   Kaji, Toshiyuki ^a  

^a HOKURIKU UNIVERSITY   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE FOR MINAMATA DISEASE   (Japan)

^d Health and Nursing Facilities for the Aged   (Japan)

Author keywords

Endothelial cell; Fibroblast growth factor 2; Methylmercury; Microvascular

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MESSENGER RNA; METHYLMERCURY; PERLECAN;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL CULTURE; INHIBITION KINETICS; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; WOUND HEALING;

EID: 68549128664     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.433     Document Type: Article

References (25)

1. Abbott, J.N., Rönnbäck, L. and Hansson, E. (2006): Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci., 7, 41-53.
2. Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G. and Yayon, A. (1994a): Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell, 79, 1005-1013.
3. Aviezer, D., Levy, E., Safran, M., Svahn, C, Buddecke, E., Schmidt, A., David, G, Vlodavsky, I. and Yayon, A. (1994b): Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem., 269, 114-121.
4. Bakir, F., Damluji, S.R, Amin-Zaki, L., Murtadha, M., Khalidi, A., Al-Rawi, N.Y, Tikriti, S., Dhahir, H.I., Clarkson, TW., Smith, J.C and Doherty, R.A. (1973): Methylmercury poisoning in Iraq: An interuniversity report. Science, 181, 230-241.
5. Bertossi, M., Girolamo, F., Errede, M., Virgintino, D., Elia, G, Ambrosi, L. and Roncali, L. (2004): Effects of methylmercury on the micro vasculature of the developing brain. Neurotoxicology, 25, 849-857. (Pubitemid 39013333)
6. Bikfalvi, A., Klein, S., Pintucci, G and Rifkin, D.B. (1997): Biological roles of fibroblast growth factor-2. Endocr. Rev., 18, 26-45.
7. Eto, K. (1997): Pathology of Minamata disease. Toxicol. Pathol., 25,614-623.
8. Eto, K, Yasutake, A., Kuwana, T, Korogi, Y, Akima, M., Shimozeki, T., Tokunaga, H. and Kaneko, Y (2001): Methylmercury poisoning in common marmosets-a study of selective vulnerability within the cerebral cortex. Toxicol. Pathol., 29, 565-573.
9. Flaumenhaft, R., Moscatelli, D., Saksela, O. and Rifkin, D.B. (1989): Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J. Cell. Physiol., 140, 75-81.
10. Fujiwara, Y and Kaji, T (1999a): Possible mechanism for lead inhibition of vascular endothelial cell proliferation: a lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis. Toxicology, 133, 147-157. (Pubitemid 29241869)
11. Fujiwara, Y and Kaji, T (1999b): Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture. Toxicology, 133,159-169. (Pubitemid 29241870)
12. Fujiwara, Y and Kaji, T. (2000): Inhibition of the repair of injured endothelial cell monolayers by lead and its possible mechanisms. J. Health Sei., 46, 1-4. (Pubitemid 30133797)
13. Fujiwara, Y, Kaji, T., Sakurai, S., Sakamoto, M. and Kozuka, H. (1997): Inhibitory effect of lead on the repair of wounded monolayers of cultured vascular endothelial cells. Toxicology, 117, 193-198. (Pubitemid 27087493)
14. Hirooka, T, Fujiwara, Y, Yamamoto, C, Yasutake, A. and Kaji, T (2007): Methylmercury retards the repair of wounded monolayer of human brain microvascular endothelial cells by inhibiting their proliferation without nonspecific cell damage. J. Health Sei., 53, 450-456. (Pubitemid 47196248)
15. Iencean, S.M. (2003): Brain edema- a new classification. Med. Hypotheses, 61, 106-109.
16. Kaji, T, Fujiwara, Y, Hoshino, M., Yamamoto, C, Sakamoto, M. and Kozuka, H. (1995): Inhibitory effect of lead on the proliferation of cultured vascular endothelial cells. Toxicology, 95, 87-92.
17. Knox, S., Merry, C, Stringer, S., Melrose, J. and Whitelock, J. (2002): Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors. J. Biol. Chem., 277, 14657-14665.
18. Marmarou, A. (2004): The pathophysiology of brain edema and elevated intracranial pressure. Cleve. Clin. J. Med., 71 Suppl 1, 6-8.
19. Rifkin, D.B. and Moscatelli, D. (1989): Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol., 109, 1-6.
20. Saksela, O., Moscatelli, D., Sommer, A. and Rifkin, D.B. (1988): Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol., 107, 743-751. (Pubitemid 18203790)
21. Sanfeliu, C, Sebastià, J., Cristòfol, R. and Rodríguez-Farré, E. (2003): Neurotoxicity of organomercurial compounds. Neurotox. Res., 5, 283-306.
22. Sato, Y and Rifkin, D.B. (1988): Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J. Cell Biol., 107, 1199-1205.
23. Yamamoto, C, Deng, X., Fujiwara, Y and Kaji, T (2005): Proteoglycans predominantly synthesized by human brain microvascular endothelial cells in culture are perlecan and biglycan. J. Health Sci., 51, 576-583.
24. Yayon, A., Klagsbran, M., Esko, J.D., Leder, P. and Ornitz, D.M. (1991): Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 64, 841-848.
25. Zheng, W., Aschner, M. and Ghersi-Egea, J.F. (2003): Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol. Appl. Pharmacol., 192, 1-11.